InvestorsHub Logo
icon url

jeffryer1

02/20/22 12:43 PM

#104528 RE: jeffryer1 #104527

Well the link didn't work. search on Regen Biopharma and Lilly 2016.
icon url

29YEARINVESTOR

02/20/22 12:51 PM

#104529 RE: jeffryer1 #104527

Yep! Way back just like This Patent. Is this patent the Key?
This patent application also goes back and was filed 11-29-16.
It just got granted 2-8-22

https://uspto.report/patent/grant/11,241,427
icon url

SidVicious

02/20/22 2:33 PM

#104530 RE: jeffryer1 #104527

You should bring up Lily's press release on the ground breaking deal with Regen. The CEO of lilly said a lot of great things about David Koos and Regen. I am sure 29inv will post the link. If not ask him for it
icon url

Musical Shares

02/20/22 2:45 PM

#104531 RE: jeffryer1 #104527

You are very misconstrued about the relationship between Regen and Eli Lilly.

Eli never "actually" worked with Regen.

That's not how it worked with the open innovation drug discovery program.

Absolutely any company could work through this open program. It wasn't like Eli picked Regen to work with them... it was an "open invitation" to ANY company.

The Open Innovation Drug Discovery platform utilizes a secure website that offers Lilly's proprietary computational and informatics tools to aid scientists in the design and selection of molecules. Once a scientist submits a molecule to the website and it meets certain specified requirements, Lilly tests it — free of charge — in a series of biological assay panels that evaluate it for its uniqueness and potential to be further optimized into a drug candidate. Comprehensive data reports are then provided to the submitting scientist.



Please see the link below for further information about the program.

https://investor.lilly.com/news-releases/news-release-details/lilly-launches-open-innovation-drug-discovery-platform-help-find